Endorsements and Letters of Support

CAEP Endorsement Submissions

To submit an item for endorsement or have a CAEP letter of support considered, please contact Shanna Scarrow sscarrow@caep.ca who can guide you through the process.
For endorsements, please submit final versions. Once endorsed, any changes will require re-endorsement.
For letter of support, we ask that you provide a draft letter for CAEP edit/review.

CAEP Current Endorsement

Geriatric Emergency Department GuidelinesCAEPACEP
2013February 2016Geriatric ED Guidelines
FASTCAEPHeart and Stroke FoundationJanuary 2015May 2015FAST (English)
FAST (Français)
Ebola: A guide for clinicians in CanadaCAEP

Canadian Critical Care Society


Association of Medical Microbiology and Infectious Diseases Canada

October 28, 2014

November 24, 2014

Updated: May 2015

Ebola: A guide for clinicians in Canada
Guidelines for Diagnosing and Managing Pediatric ConcussionCAEPOntario Neurotrauma FoundationJune 2014(1st Edition)September 2014Pediatric Concussion Guidelines
Recommendations for policy development regarding sport-related concussion prevention and management in CanadaCAEPCanadian Concussion CollaborativeJuly 12, 2014May 2014Sports-related concussion prevention and management in Canada

CAEP Endorsement Guidelines

Board-approved November 2014


CAEP endorsement means that subsequent to a review, CAEP supports, approves or recommends a program, initiative or product for a specified time period. Endorsements can be given to programs not developed or administered by CAEP recognizing that there is a limitation to the control CAEP has over the final products. Endorsement does not imply any support, financial or otherwise, unless otherwise indicated upon endorsement.


2.1. Requirements

2.1.1. Successful proposals must have objectives consistent with CAEP’s vision: “Empowered. Connected. Represented.” and mission: “CAEP’s mission is to promote the interests of emergency physicians and the specialty of Emergency Medicine in Canada by: advocating for emergency physicians and their patients; connecting emergency physicians; leading Emergency Medicine education; providing a forum for research in Emergency Medicine.”

2.1.2. Proposals for endorsement are required to be sponsored by a current CAEP member.

2.1.3. Proposals are required to be submitted in writing for review by the CAEP office, responsible committee (or section) and CAEP Board (or CAEP President or Executive Committee [which will be referred to as the Executive, herein]).

2.2. Approval considerations

2.2.1. Endorsements are ultimately the responsibility of the CAEP Board.

2.2.2. Subsequent to the endorsement approval by the President or Executive, the endorsement becomes part of the Consent agenda.

2.2.3. Endorsements are issued by the CAEP Office, subsequent to CAEP Board/Executive approval.

2.2.4. All endorsements are time-limited approvals, and the maximum time frame is three (3) years, when re-application is required.

2.2.5. If substantive changes to the program are anticipated prior to the expiration of the endorsement period, then an update outlining the proposed changes is required.

2.3. Financial considerations

2.3.1. Value of the proposal/program, not financial profit, will be a consideration in the approval process.

2.3.2. The proposal will be evaluated to ensure it is free of bias and has been prepared without undue influence on the part of financial supporters.

2.3.3. CAEP recognizes that its endorsement on programs and other initiatives has value, and under the appropriate circumstances, CAEP may be compensated for provision of the endorsement.

2.4. Standards

2.4.1. All submissions for endorsement must comply with the provisions of the Canadian Medical Association (CMA) policy entitled Physicians and the Pharmaceutical Industry (2007).

2.4.2. Where submissions for endorsement (such as standards, guidelines, and research proposals) are based on research evidence that evidence will be based on a mutually agreed upon validation model. Currently, the AGREE model is used.

2.4.3. If there is a conflict of interest, then those involved will recuse themselves from the deliberations.

2.5. Language requirements

2.5.1. Where the documents presented for endorsement involve written material intended for distribution nation-wide and those written materials are planned to be distributed in both French and English, then those written materials are to be submitted for review in both languages.

2.6. Appeals

2.6.1. The decision of the Board is final and not subject to appeal.


For a document in which a CAEP member has contributed (e.g., externally published position statement or guideline), the CAEP member will be invited to submit it for CAEP endorsement and the associated benefits.

3.1. Academic Proposals

3.1.1. Endorsement requests pertaining to academics will be reviewed by the Academic Section.

3.2. Advocacy

3.2.1. Programs for purpose of advocating for emergency physicians, their patients, their institutions, or the overall Canadian health are reviewed by the Public Affairs Committee.

3.3. Continuing Medical Education (CME)

3.3.1. CME endorsement requests will be reviewed by the CME Committee.

3.3.2. Endorsement for conferences will be limited to one (1) year in length.

3.3.3. With rare exceptions, CME programs that do not have accreditation by the College of Family Physicians (CCFP), Royal College of Physicians and Surgeons (RCPSC), or the equivalent governing bodies in other jurisdictions can be endorsed. Justification for the lack of accreditation and a detailed submission consistent with the requirements for accreditation by CCFP or RCPSC are required.

3.3.4. CME endorsement proposals should include information demonstrating: emergency medicine relevance; planning committee members (with names and involvement) including representation from the target audience; content developed by a (named) physician group or organization; educational techniques conducive to active participant involvement; financial support provided as an unrestricted educational grant; no restriction on the content or control of the content required by program sponsors; and any financial or other support in compliance with the CMA guidelines.

3.4. Position Statements and Guidelines

3.4.1. Position statements and guidelines are reviewed by the Standards Committee. Details need to be provided on: costs associated with accessing or using the guidelines or position statements, the distribution/access to the guideline or position statement and whom the guideline or position statement will be available to.

3.5. Public Safety, Prevention, Products and other endorsement proposals

3.5.1.These1. These programs and products will be reviewed on a case-by-case basis by the CAEP Office and President to determine what committee is best suited to review the proposal.

3.5.2. Where no suitable committee, it will be referred to the Executive or CAEP Board.

3.5.3. Where the proposal involves a product, the proposal shall contain verification that the product has been approved by the applicable authorities and regulatory bodies, such as the Canadian Standards Association (CSA).

3.6. Research proposals

3.6.1. Research proposals and funding applications are reviewed by the Research Committee.



4.1.1. The format of the submission must be in writing and be in sufficient detail to allow those involved to evaluate the proposal. It should include a brief description; content; scientific evidence (evidence quality and references); controversies ( if applicable, and applicant’s position); target audience (CAEP relevance), compatibility with CAEP vision and mission; contact information and persons involved; timing (single or ongoing [means to update]); scope (e.g., location [local, regional, national], medium); and financial details (e.g., costs to use and internal [e.g., administrative fees, honorarium, expenses], profit or non-profit and sponsorships).

4.2. PROCESS (Figure 1)

4.2.1. Proposed endorsement is submitted to CAEP (with materials as previously outlined herein).

4.2.2. Proposed endorsement is pre-screened by the CAEP Office to ensure it meets the minimum requirements, as described herein.

• CAEP Membership from the supporter of the proposed endorsement is verified.
• Diligence is used to screen the documents to identify any potential issues.

4.2.3. Proposed endorsement and materials are forwarded to the appropriate CAEP committee for expert review (according to Section 3 above) with a cover sheet to track it through the process.

• Clear cases for endorsement (e.g., major conferences or CME programs already endorsed by the RCPSC/CCFP) are forward to the CAEP Executive.
• Other endorsements are forwarded to the appropriate committee or Executive.

4.2.4. If the CAEP committee agrees to the merits, then it is forwarded to the CAEP Executive/Board for approval.

• Agreement reached through e-mail and electronic communication is sufficient to forward a proposed endorsement to the CAEP Board (teleconferences are not necessary)
• If rejected by the CAEP committee, the authors are notified by the CAEP Office

4.2.5. The CAEP Executive/Board can reject or support an endorsement received from the committee.

• If agreement is reached by the CAEP Executive, it does not need to proceed to the CAEP Board for decision, however it will be added to the Consent Agenda at the next Board meeting

4.2.6. The CAEP Office will notify the authors of the decision.

4.2.7. All CAEP-endorsed programs, initiatives, or products are listed on the CAEP website with the “CAEP Endorsement Seal” for a period of up to three (3) years.

• The endorsed material is listed under CAEP Endorsements (with the seal [Figure 2])
• The endorsed material is also listed on the appropriate CAEP webpage according to topic
• The endorsed material may be publicized via the CAEP Communiqué and other tools

Figure 2. CAEP Endorsement Seal